Literature DB >> 34919288

Human skin microbiota in health and disease: The cutaneous communities' interplay in equilibrium and dysbiosis: The cutaneous communities' interplay in equilibrium and dysbiosis.

Lene Bay1, Hans Christian Ring2,3.   

Abstract

Cutaneous microbial composition is driven by the microenvironment of the skin, as well as by internal and external factors. Local changes in the microenvironment can affect the configuration of the community, which may lead toward an imbalance of microbiota. Alterations in the microbial profile are common in both inflammatory skin diseases and chronic infections. A shift in balance within the microbiota, toward limited variation and a greater abundance of specific pathogens, may further worsen the pathogenicity of the diseases. These alterations may be prevented by topical treatment of probiotic solutions stimulating a balanced multispecies community. Compositional variations may further constitute potential biomarkers to predict flares or monitor efficacy during therapy. New approaches such as machine learning may contribute to this prediction of microbial alterations prior to the development of chronic infections and flares. This review provides insight into the composition and distribution of a healthy community of microorganisms in the skin and draws parallels with the community in chronic infections and chronic inflammatory skin diseases such acne vulgaris and Hidradenitis Suppurativa. We discuss the potential role of specific species in the pathogenesis and the possible prevention of disease exacerbation.
© 2021 Scandinavian Societies for Medical Microbiology and Pathology.

Entities:  

Keywords:  Skin microbiota; chronic wounds; clinical microbiology; inflammatory skin diseases; microbiome

Year:  2021        PMID: 34919288     DOI: 10.1111/apm.13201

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Bacteriocin BacSp222 and Its Succinylated Forms Exhibit Proinflammatory Activities Toward Innate Immune Cells .

Authors:  Justyna Śmiałek; Monika Bzowska; Alicja Hinz; Renata Mężyk-Kopeć; Kamilla Sołtys; Paweł Mak
Journal:  J Inflamm Res       Date:  2022-08-12

2.  Analysis of drug efficacy for inflammatory skin on an organ-chip system.

Authors:  Qianghua Quan; Ding Weng; Xuan Li; Quan An; Yang Yang; Bowen Yu; Yuan Ma; Jiadao Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.